142 related articles for article (PubMed ID: 12032391)
1. Effect of aspirin treatment in patients with peripheral arterial disease monitored with the platelet function analyzer PFA-100.
Roller RE; Dorr A; Ulrich S; Pilger E
Blood Coagul Fibrinolysis; 2002 Jun; 13(4):277-81. PubMed ID: 12032391
[TBL] [Abstract][Full Text] [Related]
2. Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100.
Homoncik M; Jilma B; Hergovich N; Stohlawetz P; Panzer S; Speiser W
Thromb Haemost; 2000 Feb; 83(2):316-21. PubMed ID: 10739392
[TBL] [Abstract][Full Text] [Related]
3. PFA-100 system: a new method for assessment of platelet dysfunction.
Mammen EF; Comp PC; Gosselin R; Greenberg C; Hoots WK; Kessler CM; Larkin EC; Liles D; Nugent DJ
Semin Thromb Hemost; 1998; 24(2):195-202. PubMed ID: 9579642
[TBL] [Abstract][Full Text] [Related]
4. In vitro aspirin resistance detected by PFA-100 closure time: pivotal role of plasma von Willebrand factor.
Chakroun T; Gerotziafas G; Robert F; Lecrubier C; Samama MM; Hatmi M; Elalamy I
Br J Haematol; 2004 Jan; 124(1):80-5. PubMed ID: 14675411
[TBL] [Abstract][Full Text] [Related]
5. Variables influencing Platelet Function Analyzer-100 closure times in healthy individuals.
Haubelt H; Anders C; Vogt A; Hoerdt P; Seyfert UT; Hellstern P
Br J Haematol; 2005 Sep; 130(5):759-67. PubMed ID: 16115134
[TBL] [Abstract][Full Text] [Related]
6. Lack of association between aspirin responsiveness and seven candidate gene haplotypes in patients with symptomatic vascular disease.
Kunicki TJ; Williams SA; Nugent DJ; Harrison P; Segal HC; Syed A; Rothwell PM
Thromb Haemost; 2009 Jan; 101(1):123-33. PubMed ID: 19132198
[TBL] [Abstract][Full Text] [Related]
7. The risk of false results in the assessment of platelet function in the absence of antiplatelet medication: comparison of the PFA-100, multiplate electrical impedance aggregometry and verify now assays.
Can MM; Tanboğa IH; Türkyilmaz E; Karabay CY; Akgun T; Koca F; Tokgoz HC; Keles N; Ozkan A; Bezgin T; Ozveren O; Sonmez K; Sağlam M; Ozdemir N; Kaymaz C
Thromb Res; 2010 Apr; 125(4):e132-7. PubMed ID: 19954823
[TBL] [Abstract][Full Text] [Related]
8. Functional evaluation of platelet aspirin resistance after on-pump coronary bypass grafting using multiple aggregation tests.
Kammerer I; Bach J; Saggau W; Isgro F
Thorac Cardiovasc Surg; 2011 Oct; 59(7):425-9. PubMed ID: 21437867
[TBL] [Abstract][Full Text] [Related]
9. Comparison of nine platelet function tests used to determine responses to different aspirin dosages in people with type 2 diabetes.
Harrison P; Bethel MA; Kennedy I; Dinsdale R; Coleman R; Holman RR
Platelets; 2019; 30(4):521-529. PubMed ID: 29985735
[TBL] [Abstract][Full Text] [Related]
10. Platelet dysfunction detected at high shear in patients with heart valve disease.
Francis JL
Platelets; 2000 May; 11(3):133-6. PubMed ID: 10938889
[TBL] [Abstract][Full Text] [Related]
11. Clopidogrel-induced platelet inhibition cannot be detected by the platelet function analyzer-100 system in stroke patients.
Kotzailias N; Elwischger K; Sycha T; Rinner W; Quehenberger P; Auff E; Müller C
J Stroke Cerebrovasc Dis; 2007; 16(5):199-202. PubMed ID: 17845916
[TBL] [Abstract][Full Text] [Related]
12. The impact of intravenous aspirin administration on platelet aspirin resistance after on-pump coronary artery bypass surgery.
Bach J; Kammerer I; Isgro F; Haubelt H; Vogt A; Saggau W; Hellstern P
Platelets; 2009 May; 20(3):150-7. PubMed ID: 19437331
[TBL] [Abstract][Full Text] [Related]
13. Monitoring aspirin 100 mg and clopidogrel 75 mg therapy with the PFA-100 device in patients with peripheral arterial disease.
Mueller T; Haltmayer M; Poelz W; Haidinger D
Vasc Endovascular Surg; 2003; 37(2):117-23. PubMed ID: 12669143
[TBL] [Abstract][Full Text] [Related]
14. Monitoring aspirin treatment in patients with thrombocytosis: comparison of the platelet function analyzer (PFA)-100 with optical aggregometry.
Tsantes AE; Mantzios G; Giannopoulou V; Tsirigotis P; Bonovas S; Rapti E; Mygiaki E; Kartasis Z; Sitaras NM; Dervenoulas J; Travlou A
Thromb Res; 2008; 123(1):100-7. PubMed ID: 18430462
[TBL] [Abstract][Full Text] [Related]
15. Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS.
Fuchs I; Frossard M; Spiel A; Riedmüller E; Laggner AN; Jilma B
J Thromb Haemost; 2006 Dec; 4(12):2547-52. PubMed ID: 17002662
[TBL] [Abstract][Full Text] [Related]
16. Hypersensitivity of platelets to adenosine diphosphate in patients with stable cardiovascular disease predicts major adverse events despite antiplatelet therapy.
Christie DJ; Kottke-Marchant K; Gorman RT
Platelets; 2008 Mar; 19(2):104-10. PubMed ID: 17852773
[TBL] [Abstract][Full Text] [Related]
17. Assessment of primary hemostasis by PFA-100 analysis in a tertiary care center.
Ortel TL; James AH; Thames EH; Moore KD; Greenberg CS
Thromb Haemost; 2000 Jul; 84(1):93-7. PubMed ID: 10928477
[TBL] [Abstract][Full Text] [Related]
18. [Reconfirmation of preanalytical variables and establishment of reference intervals of platelet function analyzer-100 closure times in Korean adults].
Cho YU; Chi HS; Jang S; Park CJ
Korean J Lab Med; 2007 Oct; 27(5):318-23. PubMed ID: 18094595
[TBL] [Abstract][Full Text] [Related]
19. Platelet activation predicts recurrent ischemic events after percutaneous coronary angioplasty: a 6 months prospective study.
Gianetti J; Parri MS; Sbrana S; Paoli F; Maffei S; Paradossi U; Berti S; Clerico A; Biagini A
Thromb Res; 2006; 118(4):487-93. PubMed ID: 16343603
[TBL] [Abstract][Full Text] [Related]
20. Von Willebrand factor antigen predicts response to double dose of aspirin and clopidogrel by PFA-100 in patients undergoing primary angioplasty for ST elevation myocardial infarction.
Gianetti J; Parri MS; Della Pina F; Marchi F; Koni E; De Caterina A; Maffei S; Berti S
ScientificWorldJournal; 2013; 2013():313492. PubMed ID: 24453831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
